Conditions: Classical Hodgkin Lymphoma
Interventions: Biological: CD30+ CAR T-cells; Drug: Bendamustin; Drug: Fludarabine
Sponsors: New York Medical College; University of North Carolina; Memorial Sloan Kettering Cancer Center
Not yet recruiting Conditions: Classical Hodgkin Lymphoma
Interventions: Biological: CD30+ CAR T-cells; Drug: Bendamustin; Drug: Fludarabine
Sponsors: New York Medical College; University of North Carolina; Memorial Sloan Kettering Cancer Center
Not yet recruiting
